Page last updated: 2024-08-25

mannuronic acid and Carcinoma, Ductal, Breast

mannuronic acid has been researched along with Carcinoma, Ductal, Breast in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmadi, H; Jafarnezhad-Ansariha, F; Kashefi, S; Mahmoodzadeh, H; Mirshafiey, A; Omranipour, R; Tofighi Zavareh, F1

Trials

1 trial(s) available for mannuronic acid and Carcinoma, Ductal, Breast

ArticleYear
The Anti-tumoral Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID on Treg Cells Frequency and MMP-2, MMP-9, CCL22 and TGFβ1 Gene Expression in Pre-surgical Breast Cancer Patients.
    Iranian journal of allergy, asthma, and immunology, 2019, Volume: 18, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemokine CCL22; Female; Gene Expression Regulation, Neoplastic; Hexuronic Acids; Humans; Lymphocyte Count; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1

2019